| Management of myocardial infarction shock: current status. | |
| | |
MedLine Citation:
|
PMID: 2644797 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Major advances have occurred over the last two decades in the management of myocardial infarction shock, increasing the overall in-hospital survival rate from approximately 15% to more than 50% at the present time with aggressive methods of interventional cardiology. The widespread use of intravenous thrombolytic therapy during the early hours of myocardial infarction has resulted in a decreasing incidence of shock with first myocardial infarctions. Three mechanisms bring about cardiogenic shock: (1) extensive aggregate systolic left ventricular dysfunction, (2) extensive right ventricular infarction, and (3) mechanical defects of the left and/or right ventricles attendant to ischemic dysfunction or rupture. To permit survival in cardiogenic shock, even with maximally aggressive therapy, diagnostic evaluation must be carried out concurrently with clinical stabilization of the patient. IABC is the mainstay for supporting the patient in shock during further efforts at diagnosis and definitive therapy. Definitive therapy for cardiogenic shock may include percutaneous transluminal coronary angioplasty, emergent bypass surgery, or repair of a mechanical defect. This report details the current status of knowledge with respect to pathogenesis, recognition, and definitive treatment of myocardial infarction shock. |
| | |
Authors:
|
T L Schreiber; D H Miller; B Zola |
Related Documents
:
|
19876737 - Purkinje-mediated effects in the response of quiescent ventricles to defibrillation sho... 9706277 - Changing practice patterns in the management of acute myocardial infarction complicated... 17064787 - Unusual presentation of takayasu arteritis. 3332227 - Catecholamines in critical care. 17182887 - Myocardial function, energy provision, and carnitine deficiency in experimental uremia. 12072417 - Induction of thyroid hormone-degrading deiodinase in cardiac hypertrophy and failure. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: American heart journal Volume: 117 ISSN: 0002-8703 ISO Abbreviation: Am. Heart J. Publication Date: 1989 Feb |
Date Detail:
|
Created Date: 1989-03-17 Completed Date: 1989-03-17 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 0370465 Medline TA: Am Heart J Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 435-43 Citation Subset: AIM; IM |
Affiliation:
|
Division of Cardiology, New York Hospital-Cornell Medical Center, NY 10021. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Emergency Medical Services Evaluation Studies as Topic Heart Catheterization Humans Myocardial Infarction / complications*, therapy Shock, Cardiogenic / diagnosis, etiology, therapy* |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Normal and anomalous coronary arteries: definitions and classification.
Next Document: Efficacy of medical therapy tailored for severe congestive heart failure in patients transferred for...